Nanosonics Limited · ASX:NAN
Nanosonics — Shareholder Meeting (November 2007)
31 slides from Nanosonics's shareholder meeting presentation, Nov 26, 2007
Slide 1: Business overview
For personal use only Business overview Maurie Stang – Chairman Annual General Meeting November 1 2007
Slide 2: Important Notice
Important Notice For personal use only This presentation has been prepared in good faith and with due care. However, none of Nanosonics Ltd or its directors, employees or advisers warrant or represent the accuracy or completeness of the information contained in this presentation. To the extent that
Slide 3: Nanosonics' summary
3 For personal use only Nanosonics’ summary
Slide 4: Market opportunity drivers
Market opportunity drivers For personal use only 4
Slide 5: Modes of disinfection
Modes of disinfection For personal use only • Medical instrument disinfection customers have only a few options • Nanosonics initial focus is in the heat sensitive device market currently serviced by mainly toxic and corrosive liquid disinfectants. 5
Slide 6: Ultrasound device advantages
Ultrasound device advantages For personal use only 6
Slide 7: Launch product
7 For personal use only Launch product
Slide 8: Instrument / device relationship
Instrument / device relationship Ultrasound Probes For personal use only Medical Equip OEMs • Siemens • Philips • GE • Hitachi • Toshiba • Etc Nanosonics’ device disinfects these complex probes 8
Slide 9: Market size and growth opportunity
Market size and growth opportunity For personal use only Nanosonics Launch Products • Total global market opportunity for HLD instruments is est. to be over US $3.0b * Estimates of market sizes include device and consumable sales allowing for the estimated useful life of the Disinfection devices 9
Slide 10: Commercialising novel infection control products in a global market
For personal use only Commercialising novel infection control products in a global market Geoff Marshall Annual General Meeting November 10 2007
Slide 11: Launch product
11 For personal use only Launch product
Slide 12: Nanosonics workflow advantage
Nanosonics workflow advantage For personal use only 12
Slide 13: Launch product
Launch product • Dr Schumacher stand at 2007 MEDICA in Dusseldorf For personal use only 13
Slide 14: Launch product
Launch product For personal use only • ASUM and IMED conference in Australia 14
Slide 15: Commercialisation strategy
Commercialisation strategy For personal use only 1. Focus - Carefully staged rollout of 3 products - HLD devices with a medical application initially 2. Manufacturing - low volume internally to establish quality & cost standards - then high volume could be outsourced 3. Distribution - outsourced to
Slide 16: Ultrasound global launch plan
Ultrasound global launch plan For personal use only Europe North America Australasia 16
Slide 17: Ultrasound EU launch plan
Ultrasound EU launch plan For personal use only Carefully staged rollout to other EU members 17
Slide 18: Business model and strategy
Business model and strategy For personal use only 18
Slide 19: Margin model
Margin model For personal use only Margin Distrib Gross Margin Distrib 30 – 45% Gross 35 – 42% Recommended Retail Recommended Retail Nano Revenue Drives cash Margin Drives cash Price Gross Price Nano Revenue Nano Margin Gross flow and Nano 50 – 55% flow and 55 – 70% P&L P&L COGS Nano Our cost Our co
Slide 20: Collaborative developments
Collaborative developments For personal use only 20
Slide 21: First product: Ultrasound Probe Disinfector
First product For personal use only Ultrasound Probe Disinfector • Estimate 470M+ ultrasound scans worldwide in 2008 • CAGR of 5% • Initial launch in Europe, market size of 125,000 units • Global market size 450,000 plus units • Positive reactions from customers, instrument manufacturers, medical as
Slide 22: Expected regulatory program
Expected regulatory program For personal use only 22
Slide 23: Manufacturing facility
Manufacturing facility For personal use only • Sydney facility for early production; delivers quality assurance • With quality and initial sales established, high volume manufacturing can be outsourced 23
Slide 24: Manufacturing Program
Manufacturing Program For personal use only Completed on time/budget Commission Upgraded ISO compliance, EU & Canada Sydney Facility Suppliers engaged & audited Sales Zone Manufacture CE CE devices in progress Mark Devices for Bottle manufacturing begun Testing Tooling and Tooling contract let Compo
Slide 25: Product development pipeline
Product development pipeline For personal use only Device / Market Research Prototyping Testing Registration Market Ultrasound probe disinfector European launch Aust & NZ launch US & Canada launch Japanese launch Rest of the world launch Endoscope disinfector TEE probe disinfector Sensor technology
Slide 26: People
26 For personal use only People
Slide 27: FY 2007 Milestones
FY 2007 Milestones ….. For personal use only Lodged 3 new NanoNebulent patents, further enhancing IP position Jul 2006 9 Achievement of EN ISO 13485:2003 certification for Nanosonics Nov 2006 9 Launched concept ultrasound device at MEDICA with Siemens and Philips Nov 2006 9 Successful commissioning
Slide 28: Milestones achieved since year end
Milestones achieved since year end For personal use only Advanced collaborative partner program with international healthcare groups Jul 2007 9 Achieved $750k extension to Comm. Ready grant program Aug 2007 9 Identified distributor network for Europe, expect appointments during Qtr 3 Sep 2007 9 Sign
Slide 29: Business metrics
Business metrics For personal use only @ 31st October 2007 194,535,923 @ 31st October 2007 $28,662,897 $31,000,000 Nil @ 23rd November 2007 $0.66 @ 23rd November 2007 $128 million (FTE) @ 23rd November 2007 46 @ 23rd November 2007 6 29
Slide 30: Shareholders
Shareholders ….. For personal use only Analysis of Shareholders 31st October 2007 (full diluted) 30
Slide 31: Summary
Summary …… For personal use only Prospectus milestones continue to be met Continuing strong validation of commercial opportunity Regulatory program on track for key global markets Collaborations and alliances continue to deliver opportunities Nanosonics is attracting significant enquiries from inter